Heat shock protein 27 knockdown using nucleotide-based therapies enhances sensitivity to 5-FU chemotherapy in SW480 human colon cancer cells

Takehiro Shimada, Masashi Tsuruta, Hirotoshi Hasegawa, Koji Okabayashi, Kohei Shigeta, Takashi Ishida, Yusuke Asada, Hirofumi Suzumura, Kaoru Koishikawa, Shingo Akimoto, Yuukou Kitagawa

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Heat shock protein 27 (Hsp27) is a chaperone protein of low molecular weight that is produced in response to various stresses and has a cytoprotective function. In the present study we found that there is a strong correlation between sensitivity to 5-fiuorouracil (5-FU) and the expression of Hsp27 in colorectal cancer. Apatorsen is an antisense oligonucleotide that targets Hsp27 and has various antitumor effects in some types of cancer, such as bladder and prostate. Although several clinical studies are currently studying apatorsen in many malignancies, to date no promising results have been reported for colorectal cancer. In the present study, we examined the impact of Hsp27 downregulation (via apatorsen) on 5-FU sensitivity in colon cancer both in vitro and in vivo. In vitro, apatorsen significantly decreased the levels of Hsp27 in a dose-dependent manner in human colon cancer SW480 cells. A cell proliferation assay revealed that although apatorsen did not inhibit tumor growth, it resulted in greater 5-FU sensitivity in comparison with treatment with OGX-411 (control). In vivo, intraperitoneal injection of apatorsen decreased the levels of Hsp27 in subcutaneous tumors in a xenograft mouse model using SW480 cells and enhanced 5-FU sensitivity, compared to controls. Although further research is warranted, the present study confirmed that concurrent treatment with Hsp27 knockdown using apatorsen and 5-FU could be a promising therapy for colon cancer.

Original languageEnglish
Pages (from-to)1119-1124
Number of pages6
JournalOncology Reports
Volume39
Issue number3
DOIs
Publication statusPublished - 2018 Mar 1

Fingerprint

HSP27 Heat-Shock Proteins
Colonic Neoplasms
Nucleotides
Drug Therapy
Therapeutics
Colorectal Neoplasms
Neoplasms
Antisense Oligonucleotides
Intraperitoneal Injections
Heterografts
Prostate
Urinary Bladder
Cohort Studies
Down-Regulation
Molecular Weight
Cell Proliferation
Growth

Keywords

  • Apatorsen
  • Colon cancer
  • Heat shock protein 27

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Heat shock protein 27 knockdown using nucleotide-based therapies enhances sensitivity to 5-FU chemotherapy in SW480 human colon cancer cells. / Shimada, Takehiro; Tsuruta, Masashi; Hasegawa, Hirotoshi; Okabayashi, Koji; Shigeta, Kohei; Ishida, Takashi; Asada, Yusuke; Suzumura, Hirofumi; Koishikawa, Kaoru; Akimoto, Shingo; Kitagawa, Yuukou.

In: Oncology Reports, Vol. 39, No. 3, 01.03.2018, p. 1119-1124.

Research output: Contribution to journalArticle

Shimada, Takehiro ; Tsuruta, Masashi ; Hasegawa, Hirotoshi ; Okabayashi, Koji ; Shigeta, Kohei ; Ishida, Takashi ; Asada, Yusuke ; Suzumura, Hirofumi ; Koishikawa, Kaoru ; Akimoto, Shingo ; Kitagawa, Yuukou. / Heat shock protein 27 knockdown using nucleotide-based therapies enhances sensitivity to 5-FU chemotherapy in SW480 human colon cancer cells. In: Oncology Reports. 2018 ; Vol. 39, No. 3. pp. 1119-1124.
@article{544f68cc86504b1096d56bb5d19960e8,
title = "Heat shock protein 27 knockdown using nucleotide-based therapies enhances sensitivity to 5-FU chemotherapy in SW480 human colon cancer cells",
abstract = "Heat shock protein 27 (Hsp27) is a chaperone protein of low molecular weight that is produced in response to various stresses and has a cytoprotective function. In the present study we found that there is a strong correlation between sensitivity to 5-fiuorouracil (5-FU) and the expression of Hsp27 in colorectal cancer. Apatorsen is an antisense oligonucleotide that targets Hsp27 and has various antitumor effects in some types of cancer, such as bladder and prostate. Although several clinical studies are currently studying apatorsen in many malignancies, to date no promising results have been reported for colorectal cancer. In the present study, we examined the impact of Hsp27 downregulation (via apatorsen) on 5-FU sensitivity in colon cancer both in vitro and in vivo. In vitro, apatorsen significantly decreased the levels of Hsp27 in a dose-dependent manner in human colon cancer SW480 cells. A cell proliferation assay revealed that although apatorsen did not inhibit tumor growth, it resulted in greater 5-FU sensitivity in comparison with treatment with OGX-411 (control). In vivo, intraperitoneal injection of apatorsen decreased the levels of Hsp27 in subcutaneous tumors in a xenograft mouse model using SW480 cells and enhanced 5-FU sensitivity, compared to controls. Although further research is warranted, the present study confirmed that concurrent treatment with Hsp27 knockdown using apatorsen and 5-FU could be a promising therapy for colon cancer.",
keywords = "Apatorsen, Colon cancer, Heat shock protein 27",
author = "Takehiro Shimada and Masashi Tsuruta and Hirotoshi Hasegawa and Koji Okabayashi and Kohei Shigeta and Takashi Ishida and Yusuke Asada and Hirofumi Suzumura and Kaoru Koishikawa and Shingo Akimoto and Yuukou Kitagawa",
year = "2018",
month = "3",
day = "1",
doi = "10.3892/or.2018.6180",
language = "English",
volume = "39",
pages = "1119--1124",
journal = "Oncology Reports",
issn = "1021-335X",
publisher = "Spandidos Publications",
number = "3",

}

TY - JOUR

T1 - Heat shock protein 27 knockdown using nucleotide-based therapies enhances sensitivity to 5-FU chemotherapy in SW480 human colon cancer cells

AU - Shimada, Takehiro

AU - Tsuruta, Masashi

AU - Hasegawa, Hirotoshi

AU - Okabayashi, Koji

AU - Shigeta, Kohei

AU - Ishida, Takashi

AU - Asada, Yusuke

AU - Suzumura, Hirofumi

AU - Koishikawa, Kaoru

AU - Akimoto, Shingo

AU - Kitagawa, Yuukou

PY - 2018/3/1

Y1 - 2018/3/1

N2 - Heat shock protein 27 (Hsp27) is a chaperone protein of low molecular weight that is produced in response to various stresses and has a cytoprotective function. In the present study we found that there is a strong correlation between sensitivity to 5-fiuorouracil (5-FU) and the expression of Hsp27 in colorectal cancer. Apatorsen is an antisense oligonucleotide that targets Hsp27 and has various antitumor effects in some types of cancer, such as bladder and prostate. Although several clinical studies are currently studying apatorsen in many malignancies, to date no promising results have been reported for colorectal cancer. In the present study, we examined the impact of Hsp27 downregulation (via apatorsen) on 5-FU sensitivity in colon cancer both in vitro and in vivo. In vitro, apatorsen significantly decreased the levels of Hsp27 in a dose-dependent manner in human colon cancer SW480 cells. A cell proliferation assay revealed that although apatorsen did not inhibit tumor growth, it resulted in greater 5-FU sensitivity in comparison with treatment with OGX-411 (control). In vivo, intraperitoneal injection of apatorsen decreased the levels of Hsp27 in subcutaneous tumors in a xenograft mouse model using SW480 cells and enhanced 5-FU sensitivity, compared to controls. Although further research is warranted, the present study confirmed that concurrent treatment with Hsp27 knockdown using apatorsen and 5-FU could be a promising therapy for colon cancer.

AB - Heat shock protein 27 (Hsp27) is a chaperone protein of low molecular weight that is produced in response to various stresses and has a cytoprotective function. In the present study we found that there is a strong correlation between sensitivity to 5-fiuorouracil (5-FU) and the expression of Hsp27 in colorectal cancer. Apatorsen is an antisense oligonucleotide that targets Hsp27 and has various antitumor effects in some types of cancer, such as bladder and prostate. Although several clinical studies are currently studying apatorsen in many malignancies, to date no promising results have been reported for colorectal cancer. In the present study, we examined the impact of Hsp27 downregulation (via apatorsen) on 5-FU sensitivity in colon cancer both in vitro and in vivo. In vitro, apatorsen significantly decreased the levels of Hsp27 in a dose-dependent manner in human colon cancer SW480 cells. A cell proliferation assay revealed that although apatorsen did not inhibit tumor growth, it resulted in greater 5-FU sensitivity in comparison with treatment with OGX-411 (control). In vivo, intraperitoneal injection of apatorsen decreased the levels of Hsp27 in subcutaneous tumors in a xenograft mouse model using SW480 cells and enhanced 5-FU sensitivity, compared to controls. Although further research is warranted, the present study confirmed that concurrent treatment with Hsp27 knockdown using apatorsen and 5-FU could be a promising therapy for colon cancer.

KW - Apatorsen

KW - Colon cancer

KW - Heat shock protein 27

UR - http://www.scopus.com/inward/record.url?scp=85041742977&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041742977&partnerID=8YFLogxK

U2 - 10.3892/or.2018.6180

DO - 10.3892/or.2018.6180

M3 - Article

C2 - 29328475

AN - SCOPUS:85041742977

VL - 39

SP - 1119

EP - 1124

JO - Oncology Reports

JF - Oncology Reports

SN - 1021-335X

IS - 3

ER -